Innovative Vaccine Solutions for Global Health

We are Baxiva, a biotechnology startup dedicated to revolutionizing glycoconjugate vaccine development. Our focus is on creating innovative solutions to combat bacterial infections, including those most commonly associated with urinary tract infections.